Protocol summary

Study aim
Comparison of the effect of 25% hypertonic dextrose prolotherapy injection under ultrasound guidance with intra-articular injection of normal saline under ultrasound guidance in patients with chronic knee pain referred to Shiraz medical science training centers in improving pain and function and knee range of motion
Design
double-blind randomized clinical trial with a control group
Settings and conduct
The patient select from emam reza clinic and rajaee hospital who has knee OA.then patient divided into two groups and after obtaining written consent the study begins. in intervention group hypertonic dextrose is injected and in control group normalsaline is injected then we measure its effect on reducing pain and improving patient function and knee range of motion
Participants/Inclusion and exclusion criteria
The entry conditions include the age of the patients, patients 55-75 years old with pain or limitation of the range of motion of the knee for more than three months. Gender: male or female. Anterolateral knee x-ray taken in the last 3 months while standing. exclusion conditions: patients with inflammatory diseases and vascular collagen such as lupus and suspicion of knee infection, patients with coagulation disorders, patients with active lumbosacral radiculopathy and severe deformity of the spine and lower limbs, nervous system disorders, being pregnant , diabetes, A history of surgery on the knee, injection CS in the last two months, or intra-articular injection of hyaluronic acid in the last 12 months, or replacement of the knee joint, use of opioid drugs, body mass index above 40 should not be included in the study.
Intervention groups
Intervention group: The group that received 25% dextrose medicine intra-articularly in the knee. Control group: The group that receives normal saline intra-articularly.
Main outcome variables
Pain, Activity of daily living, knee range of motion

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT20221111056470N1
Registration date: 2022-12-10, 1401/09/19
Registration timing: registered_while_recruiting

Last update: 2022-12-10, 1401/09/19
Update count: 0
Registration date
2022-12-10, 1401/09/19
Registrant information
Name
Nafiseh Birang
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 31 3624 1170
Email address
nafis_bg@yahoo.com
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2022-11-16, 1401/08/25
Expected recruitment end date
2022-12-16, 1401/09/25
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Comparison between the efficacy of ultrasound-guided dextrose 25% hypertonic prolotherapy and intraarticular normal saline injection on pain, functional limitation and range of motion; in knee osteoarthritis patients
Public title
Comparison between the efficacy of ultrasound-guided dextrose 25% hypertonic prolotherapy and intraarticular normal saline injection on pain, functional limitation and range of motion; in knee osteoarthritis patients
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Inclusion criteria: aged 55 to75 years; both genders; knee radiography anterior standing view have been for the last one month; have symptoms of osteoarthritis include pain, limitation in knee range of motion , and knee joint dryness for at least a month without any extra-articular involvement.
Exclusion criteria:
Inflammatory and vascular collagen diseases such as lupus and suspected knee infection, patients with coagulation disorders, patients with active lumbosacral radiculopathy and severe deformity of the spine and lower limbs, peripheral and central nervous system disorders, pregnancy, diabetes, history of surgery on the knee, injection of steroid drugs in the last two months or intra-articular injection of hyaluronic acid in the last 12 months or replacement of the knee joint, use of opioid drugs, body mass index over 40
Age
From 55 years old to 75 years old
Gender
Both
Phase
N/A
Groups that have been masked
  • Participant
  • Outcome assessor
  • Data analyser
Sample size
Target sample size: 50
Randomization (investigator's opinion)
Randomized
Randomization description
To match patients in the intervention and control groups, patients are randomly assigned to one of two treatment groups. The random allocation method in this study will be the permutation blocks randomization method with 4 samples in each block and a random list of data will be obtained by using Random Allocation software. We will have two lists of 25patients, including the two intervention and control groups, at random. For concealment, method of random sequencing is given to another person who is unaware of the research process, and the questionnaires are completed by a person unaware of the division of groups
Blinding (investigator's opinion)
Double blinded
Blinding description
Participant: The participant is explained that if they are interested, they can join our research project. two methods used to reduce patient pain input study are explained to the patient. Benefits and possible complications of both methods are described to the patient and the patient is told to randomly fall into one of the intervention groups. If the patient is accepted to admit the study, by random allocation soft ware, the patient falls in to one of two groups. Clinical car giver: we teach the caregiver how to complete the questionnaier. This person is not aware of receiving patient intervention. Researcher: In this study does not have the ability to blind the reseacher because the researcher performs both intervention himself and is aware of receiving each intervention in the group. The outcome assessor of the complete questionnaires is given to person who is not aware of the interventions performed and he/she is asked to determine the level of performance in each person according to the questionnaires. Date analyzer: questionnaire are finally given to a person to review the information. This person doesn't know any of the steps of the work, how to classify and the intervention performed.
Placebo
Not used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics committee of Shiraz University of Medical Sciences
Street address
No. 103., Sadi Dead End., Bijan Alley., Hakim Nezami Ave
City
Esfahan
Province
Isfehan
Postal code
8175979967
Approval date
2022-11-12, 1401/08/21
Ethics committee reference number
IR.SUMS.MED.REC.1401.246

Health conditions studied

1

Description of health condition studied
knee osteoarthritis
ICD-10 code
M17
ICD-10 code description
Osteoarthritis of knee

Primary outcomes

1

Description
Pain scale
Timepoint
Just before the intervention & 2,4,8 weeks later.
Method of measurement
Visual Analogue Scale,Western Ontario and McMaster Universities Arthritis Index (WOMAC)

2

Description
Knee flexion degree
Timepoint
Just before the intervention & 2,4,8 weeks later.
Method of measurement
goniometry

Secondary outcomes

1

Description
functional limitation
Timepoint
Just before the intervention & 2,4,8 weeks later.
Method of measurement
Oxford knee score and Western Ontario and McMaster Universities Arthritis Index (WOMAC)

Intervention groups

1

Description
Intervention group: The group that received 25% dextrose hyper-tonic intra-articularly under ultrasound guidance.
Category
Treatment - Drugs

2

Description
Control group: The group that received normal saline intra-articularly under ultrasound guidance.
Category
Treatment - Drugs

Recruitment centers

1

Recruitment center
Name of recruitment center
Emam reza rehabilitation clinic
Full name of responsible person
Mani Ramzi
Street address
Namazi square
City
Shiraz
Province
Fars
Postal code
7134814734
Phone
+98 71 3212 7000
Fax
Email
motahari@sums.ac.ir

2

Recruitment center
Name of recruitment center
Rajai hospital
Full name of responsible person
Amirreza Mesbahi
Street address
Chamrzn Blvd
City
Shiraz
Province
Fars
Postal code
7194815711
Phone
+98 71 3636 4001
Email
Rajaeehospital@sums.ac.ir

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Shiraz University of Medical Sciences
Full name of responsible person
Yunes Ghasemi
Street address
In front of Ma'aref School., Khalili St
City
Shiraz
Province
Fars
Postal code
7134814336
Phone
+98 71 3628 1506
Email
Info@sums.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Shiraz University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Shiraz University of Medical Sciences
Full name of responsible person
Nafiseh Birang
Position
Resident
Latest degree
Medical doctor
Other areas of specialty/work
Physical Medicine
Street address
No. 103., Sadi Dead End., Bijan Alley., Hakim Nezami Ave
City
Esfahan
Province
Isfehan
Postal code
8175979967
Phone
+98 31 3624 1170
Email
nafis_bg@yahoo.com

Person responsible for scientific inquiries

Contact
Name of organization / entity
Shiraz University of Medical Sciences
Full name of responsible person
Nafiseh Birang
Position
Resident
Latest degree
Medical doctor
Other areas of specialty/work
Physical Medicine
Street address
No. 103., Sadi Dead End., Bijan Alley., Hakim Nezami Ave
City
Esfahan
Province
Isfehan
Postal code
8175979967
Phone
+98 31 3624 1170
Email
nafis_bg@yahoo.com

Person responsible for updating data

Contact
Name of organization / entity
Shiraz University of Medical Sciences
Full name of responsible person
Nafiseh Birang
Position
Resident
Latest degree
Medical doctor
Other areas of specialty/work
Physical Medicine
Street address
No. 103., Sadi Dead End., Bijan Alley., Hakim Nezami Ave
City
Esfahan
Province
Isfehan
Postal code
8175979967
Phone
+98 31 3624 1170
Email
nafis_bg@yahoo.com

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Yes - There is a plan to make this available
Study Protocol
Yes - There is a plan to make this available
Statistical Analysis Plan
Yes - There is a plan to make this available
Informed Consent Form
Yes - There is a plan to make this available
Clinical Study Report
Yes - There is a plan to make this available
Analytic Code
Yes - There is a plan to make this available
Data Dictionary
Yes - There is a plan to make this available
Title and more details about the data/document
All available data can be shared after making people unidentifiable.
When the data will become available and for how long
Start access period one year after publishing the results.
To whom data/document is available
everyone can access to this information.
Under which criteria data/document could be used
if the information in this study helps to improve the science process.
From where data/document is obtainable
nafis_bg@yahoo.com 00989132052155
What processes are involved for a request to access data/document
After sending the desired message, all authors of the study will be consulted all information will be sent within a maximum of three weeks if permitted
Comments
Loading...